| First Author | Zhou Y | Year | 2020 |
| Journal | Sci Transl Med | Volume | 12 |
| Issue | 537 | PubMed ID | 32238574 |
| Mgi Jnum | J:286849 | Mgi Id | MGI:6404970 |
| Doi | 10.1126/scitranslmed.aax1798 | Citation | Zhou Y, et al. (2020) PBX1 expression in uterine natural killer cells drives fetal growth. Sci Transl Med 12(537) |
| abstractText | Abundant decidual natural killer (dNK) cells at the maternal-fetal interface are important during early pregnancy. However, functional subsets of dNK cells remain poorly understood. We describe a CD49a(+)PBX homeobox 1 (PBX1)(+) dNK cell subset that promotes fetal development in humans and mice. The expression of PBX1 in dNK cells is up-regulated via the activated AKT1 pathway through the interaction of major histocompatibility complex G with the immunoglobulin-like transcript 2 receptor. PBX1 drives pleiotrophin and osteoglycin transcription in dNK cells, further promoting fetal development. Decreased PBX1 expression or the PBX1(G21S) mutant correlated with fetal growth restriction and pregnancy failure in patients with unexplained recurrent spontaneous abortion (URSA). Inactivation of Pbx1 in mouse dNK cells impairs fetal development by decreasing growth-promoting factors from CD49a(+)PBX1(+) dNK cells. Impairment of PBX1 in dNK cells has positive correlation with URSA pathogenesis and may provide a potential marker for this condition. |
